Robson Spinola
Podiatrist · Jesup, GANPI 1912942418
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,500 of the $15,392 with a category attached, or 87.7%. Intelivation Technologies, LLC accounts for 91.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $12,614 and has fallen 99.1% since, to $108 in 2025. Among podiatrist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $732.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intelivation Technologies, LLC$14K
- Paragon 28, Inc.$1K
- Biocomposites Inc$53
- AbbVie$34
- Davol Inc.$30
- Treace Medical Concepts, Inc.$23
- plus $48 from 3 others
What the payments were for
- Consulting fees$13,50088%
- Travel & lodging$1,48910%
- Food & beverage$4033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intelivation Technologies, LLC | 3 | $14,119 |
| Paragon 28, Inc. | 9 | $1,086 |
| Biocomposites Inc | 2 | $53 |
| AbbVie | 2 | $34 |
| Davol Inc. | 1 | $30 |
| Treace Medical Concepts, Inc. | 1 | $23 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $14 |
| Smith+Nephew | 1 | $14 |
How this compares
$15,392 in reported general payments places this provider in the 95th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 346 | $6,129 |
| CiclopiroxCiclopirox Olamine | 301 | $3,467 |
| Pregabalin | 136 | $3,152 |
| Ciclopirox | 57 | $2,006 |
| Diclofenac Sodium | 52 | $1,446 |
| Mupirocin | 155 | $1,323 |
| Duloxetine Hcl | 90 | $1,305 |
| Colchicine | 21 | $1,131 |
| Ammonium Lactate | 42 | $879 |
| Terbinafine Hcl | 76 | $853 |
| Ketoconazole | 32 | $537 |
| Allopurinol | 104 | $482 |
| Meloxicam | 160 | $475 |
| Cephalexin | 80 | $446 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $390 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Jesup
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Christopher CorwinJohns Creek$15K
- Nathan TirabassiSmyrna$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.